Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets

Page 1 of 5

In this article, we discuss the 5 stocks receiving price-target hike from Wall Street analysts. If you want to see more such stocks on the list, go directly to Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets.

05. Akero Therapeutics, Inc. (NASDAQ:AKRO)

Upside Potential: 24%

On September 5, JPMorgan Chase & Co. made a significant adjustment in evaluating Akero Therapeutics, Inc. (NASDAQ:AKRO). JPMorgan Chase took a noteworthy step by increasing the company’s price target from $49.00 to a more optimistic target of $62.00. This represents a 24% upside potential for Akero Therapeutics, Inc. (NASDAQ:AKRO) stock compared to its current price of $49.97. Importantly, JPMorgan Chase & Co. retained its “Overweight” rating for Akero Therapeutics, Inc. (NASDAQ:AKRO). This move underscores JPMorgan Chase’s continued confidence in Akero Therapeutics, Inc. (NASDAQ:AKRO). It conveys their belief that Akero Therapeutics, Inc. (NASDAQ:AKRO) stock not only justifies its existing “Overweight” rating but also possesses the potential to reach the newly established target of $62.00.

Page 1 of 5